UB Paderborn / Katalog / Suche / in CDI

Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study

Breast cancer research and treatment, 2012-07, Vol.134 (1), p.353-362

2012

Link zum Volltext

Verfügbarkeit prüfen

Perometry versus simulated circumferential tape measurement for the detection of breast cancer-related lymphedema

Breast cancer research and treatment, 2018-11, Vol.172 (1), p.83-91

2018

Link zum Volltext

Verfügbarkeit prüfen

Racial disparities in breast cancer persist despite early detection: analysis of treatment of stage 1 breast cancer and effect of insurance status on disparities

Breast cancer research and treatment, 2019-02, Vol.173 (3), p.597-602

2019

Link zum Volltext

Verfügbarkeit prüfen

Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis

Breast cancer research and treatment, 2019-01, Vol.173 (2), p.329-341

2019

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with improved outcomes for metastatic inflammatory breast cancer patients

Breast cancer research and treatment, 2018-06, Vol.169 (3), p.615-623

2018

Link zum Volltext

Verfügbarkeit prüfen

Survival of women diagnosed with breast cancer and who have survived a previous cancer

Breast cancer research and treatment, 2021-06, Vol.187 (3), p.853-865

2021

Link zum Volltext

Verfügbarkeit prüfen

Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials

Breast cancer research and treatment, 2019-02, Vol.174 (1), p.27-37

2019

Link zum Volltext

Verfügbarkeit prüfen

Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up

Breast cancer research and treatment, 2016-06, Vol.157 (2), p.363-371

2016

Link zum Volltext

Verfügbarkeit prüfen

Association of sarcopenia with endocrine therapy toxicity in patients with early breast cancer

Breast cancer research and treatment, 2022-11, Vol.196 (2), p.323-328

2022

Link zum Volltext

Verfügbarkeit prüfen

Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan

Breast cancer research and treatment, 2017, Vol.161 (2), p.191-201

2017

Link zum Volltext

Verfügbarkeit prüfen

Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine

Breast cancer research and treatment, 2020-11, Vol.184 (2), p.559-565

2020

Link zum Volltext

Verfügbarkeit prüfen

Racial inequities in second-line treatment and overall survival among patients with metastatic breast cancer

Breast cancer research and treatment, 2022-11, Vol.196 (1), p.163-173

2022

Link zum Volltext

Verfügbarkeit prüfen

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

Breast cancer research and treatment, 2019-01, Vol.173 (2), p.343-352

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastases

Breast cancer research and treatment, 2020, Vol.179 (1), p.113-123

2020

Link zum Volltext

Verfügbarkeit prüfen

Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer

Breast cancer research and treatment, 2019-04, Vol.174 (2), p.443-452

2019

Link zum Volltext

Verfügbarkeit prüfen

Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone

Breast cancer research and treatment, 2019-07, Vol.176 (2), p.377-386

2019

Link zum Volltext

Verfügbarkeit prüfen

Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis

Breast cancer research and treatment, 2021-08, Vol.189 (1), p.63-80

2021

Link zum Volltext

Verfügbarkeit prüfen

miRNA-34a is associated with docetaxel resistance in human breast cancer cells

Breast cancer research and treatment, 2012-01, Vol.131 (2), p.445-454

2012

Link zum Volltext

Verfügbarkeit prüfen

The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer

Breast cancer research and treatment, 2018-08, Vol.170 (3), p.647-656

2018

Link zum Volltext

Verfügbarkeit prüfen

Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial

Breast cancer research and treatment, 2012-06, Vol.133 (3), p.1067-1075

2012

Link zum Volltext

Verfügbarkeit prüfen

Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy

Breast cancer research and treatment, 2018-11, Vol.172 (1), p.69-82

2018

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer

Breast cancer research and treatment, 2015-05, Vol.151 (1), p.169-176

2015

Link zum Volltext

Verfügbarkeit prüfen

Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy

Breast cancer research and treatment, 2019-02, Vol.174 (1), p.1-13

2019

Link zum Volltext

Verfügbarkeit prüfen

Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990–2011

Breast cancer research and treatment, 2019-04, Vol.174 (2), p.505-514

2019

Link zum Volltext

Verfügbarkeit prüfen

Late breast cancer treatment-related symptoms and functioning: associations with physical activity adoption and maintenance during a lifestyle intervention for rural survivors

Breast cancer research and treatment, 2018-04, Vol.168 (3), p.755-761

2018

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study

Perometry versus simulated circumferential tape measurement for the detection of breast cancer-related lymphedema

Racial disparities in breast cancer persist despite early detection: analysis of treatment of stage 1 breast cancer and effect of insurance status on disparities

Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis

Factors associated with improved outcomes for metastatic inflammatory breast cancer patients

Survival of women diagnosed with breast cancer and who have survived a previous cancer

Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials

Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up

Association of sarcopenia with endocrine therapy toxicity in patients with early breast cancer

Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan

Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine

Racial inequities in second-line treatment and overall survival among patients with metastatic breast cancer

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastases

Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer

Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone

Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis

miRNA-34a is associated with docetaxel resistance in human breast cancer cells

The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer

Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial

Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy

Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer

Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy

Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990–2011

Late breast cancer treatment-related symptoms and functioning: associations with physical activity adoption and maintenance during a lifestyle intervention for rural survivors

Aktive Filter

Suchergebnisse filtern